FEATURED ARTICLES

• How To Implement Post-Approval Changes On A Global Level

  To prepare for inevitable process changes after market authorization, this overview provides critical planning advice for assessing risk and minimizing delays.

• From Principles To Practice: Building Quality Into Generative AI-Assisted Pharma Operations
• From QM To QMM For AI-Assisted Pharmaceutical Manufacturing Operations
• Preventive Maintenance Isn't Enough For GMP Manufacturers
• Proactive EAM Automation For Compliance And Efficiency

WHITE PAPERS & CASE STUDIES

• A Guide To Process Transparency In Custom Lab Automation Development

  Discover a practical guide to building custom automation systems with clarity and confidence, as well as how transparent processes reduce risk, prevent misalignment, and support reliable testing.

• Can Your Biopharma Team Keep Unplanned Downtime At Bay?

  Learn how teams reduce downtime, strengthen compliance, and respond quickly to equipment issues through proactive maintenance, smart spare parts planning, and digital troubleshooting tools.

• Alleviate Compliance Risks With Your EAM/CMMS

  Discover how unified asset management enhances audit readiness by connecting maintenance, calibration, and quality insights, as well as how integrated workflows reduce compliance risk.

• Soil Testing: From Filtration To Fertilizer To Food

  Soil analysis offers a clear view of the factors that influence land productivity while helping identify contaminants that could threaten safety. Understand the indicators to support sustainability decisions.

• Digital Solutions Enhance Pharmaceutical Manufacturing Performance

  Personalised therapies and advanced technologies are reshaping manufacturing. Explore how intelligent automation can improve flexibility, strengthen data integrity, and accelerate production.

• Activate Advanced Contamination Control Technology To Safeguard Your Cell Therapy

  The most common contamination risks in cell therapy manufacturing are open processes that leverage different products, inflexible instruments, labor intensive workflows, lack of in-line monitoring, and zero failure tolerance.